The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside in prevention of oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer patients.
 
Yu-hong Li
No Relationships to Disclose
 
De-Shen Wang
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Jie-wen Peng
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Fen Feng
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Jianwei Zhang
No Relationships to Disclose
 
Fenghua Wang
No Relationships to Disclose
 
Chao Ren
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Ying Jin
No Relationships to Disclose
 
Chuanbo Xie
No Relationships to Disclose
 
Qiong Tan
No Relationships to Disclose
 
Gong Chen
Speakers' Bureau - Merck Serono; Roche; Sanofi
 
Rui-hua Xu
No Relationships to Disclose